BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 193 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2018. The put-call ratio across all filers is 1.70 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $290,000 | +16.9% | 2,825 | 0.0% | 0.09% | +18.2% |
| Q2 2021 | $248,000 | -9.8% | 2,825 | 0.0% | 0.08% | -11.5% |
| Q1 2021 | $275,000 | -18.2% | 2,825 | -5.6% | 0.09% | -20.2% |
| Q4 2020 | $336,000 | +20.9% | 2,994 | 0.0% | 0.11% | +2.8% |
| Q3 2020 | $278,000 | +20.9% | 2,994 | +1.5% | 0.11% | +14.0% |
| Q2 2020 | $230,000 | -22.6% | 2,950 | -41.8% | 0.09% | -35.9% |
| Q1 2020 | $297,000 | -27.9% | 5,073 | -1.4% | 0.14% | -11.0% |
| Q4 2019 | $412,000 | -5.7% | 5,146 | -13.5% | 0.16% | 0.0% |
| Q3 2019 | $437,000 | +75.5% | 5,946 | +91.5% | 0.16% | +69.8% |
| Q1 2019 | $249,000 | -26.3% | 3,105 | -50.5% | 0.10% | -34.7% |
| Q4 2018 | $338,000 | -30.9% | 6,270 | 0.0% | 0.15% | -16.0% |
| Q3 2018 | $489,000 | +124.3% | 6,270 | +82.7% | 0.18% | +133.3% |
| Q2 2018 | $218,000 | -30.8% | 3,431 | 0.0% | 0.08% | -29.9% |
| Q1 2018 | $315,000 | – | 3,431 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 716,539 | $36,192,000 | 12.35% |
| CADIAN CAPITAL MANAGEMENT, LP | 2,020,629 | $102,062,000 | 6.89% |
| Casdin Capital, LLC | 1,150,000 | $58,087,000 | 4.91% |
| DAFNA Capital Management LLC | 261,280 | $13,197,000 | 3.60% |
| Nextech Invest Ltd. | 188,228 | $9,507,000 | 3.21% |
| Eagle Health Investments LP | 170,551 | $8,615,000 | 2.01% |
| Boxer Capital, LLC | 507,374 | $25,627,000 | 1.62% |
| Rock Springs Capital Management LP | 979,174 | $49,458,000 | 1.44% |
| EFG Asset Management (North America) Corp. | 130,454 | $6,589,000 | 1.39% |
| Integral Health Asset Management, LLC | 130,000 | $6,566,000 | 1.35% |